CHO.RIGHT

What this means for you

Registered since 16 Apr 2019. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79232855

Registration number

5724306

Mark type

Stylized text

Filed

05 Apr 2018

Published for opposition

29 Jan 2019

Registered

16 Apr 2019

Attorney of record

David A.W. Wong

Goods and services

• Class 001 — Chemicals: Protein expression systems, namely, human proteins for life science and medical research
• Class 005 — Pharmaceuticals: Biological preparations for diagnostic, pharmaceutical and veterinary purposes, in particular biological preparations developed from biological cells and for use in the extraction, propagation or modification of biological cells and for the manufacture of biological active substances, bacterial enzymes; enzymes for medical purposes
• Class 009 — Scientific and electric apparatus: [ Laboratory apparatus and instruments, namely, homogenizers and systems for use in protein purification; laboratory apparatus, namely, devices for analyzing protein sequence; bioreactors for laboratory use ]
• Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of pharmaceuticals using biological organisms in the manufacturing process; custom manufacture of proteins and vaccines with the aid of biological cells, including cell design and modification of biological cells; custom manufacture of biological active substances and bacterial enzymes
• Class 042 — Scientific and technological services: Research and development in the fields of [ bacteriology, ] cellular engineering, cytology, antibodies, glycomics, [ chemistry, ] microorganisms, proteins, immunology, biological therapeutics, [ nutraceuticals ] and gene expression systems; scientific research [ and genome synthesis ] services for others; scientific and technological services, namely, research services in the fields of genetics, epigenetics and expression analysis; research and development in the biotechnology fields, namely, conducting protein expression; scientific and industrial research in the fields of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures and expression systems, namely, protein expression systems; biotechnological research relating to enzymatic synthesis; biochemistry services, namely, biochemical assays and DNA screening; research relating to biotechnology; consultancy services relating to biotechnology; design services relating to process systems for the biotechnology industry; [ design services relating to plants for the biotechnology industry; ] research and development in the pharmaceutical and biotechnology fields; scientific and industrial research and development in the field of biotechnology and protein expression systems; biological research; laboratory services in connection with the use of bacterial enzymes for synthesis purposes; medical laboratory services, namely, propagation or modification of biological cells

Owner

• ProBioGen AG, Berlin, DE
• ProBioGen AG, DE
• ProBioGen AG, DE

Prosecution history

• 18 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
• 18 Feb 2026 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
• 09 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 13 Oct 2025 — TEAS SECTION 71 & 15 RECEIVED
• 16 Apr 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
• 30 Aug 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
• 08 Aug 2019 — FINAL DISPOSITION NOTICE SENT TO IB
• 08 Aug 2019 — FINAL DISPOSITION PROCESSED
• 16 Jul 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 16 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
• 29 Jan 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 29 Jan 2019 — PUBLISHED FOR OPPOSITION
• 25 Jan 2019 — NOTIFICATION PROCESSED BY IB
• 09 Jan 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 09 Jan 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB